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Background
The RV144 vaccine showed a moderate efficacy of pro-
tection from HIV infection. The major immune response
induced by RV144 was non-neutralizing HIV-specific
antibodies (Abs), that may have potentially mediated Ab
Dependent Cellular Cytotoxicity (ADCC) and/or Ab
dependent Cellular Phagocytosis (ADCP). However little
is known about the potential role of different vaccine
regimens on inducing these types of humoral immune
responses, and whether particular vaccine approaches
may preferentially induce robust innate immune recruit-
ing antibody activity that could confer more protection
against infection. We therefore aimed to characterize the
antibody-effector functional profiles of antibodies elicited
by a number of different vaccine approaches including
those induced in the: VAX003 trial (bivalent rgp120
clade B/E), RV144 (ALVAC vCP1521 + rgp120 B/E),
IPCAVD001 (rAd26.ENVA.01), IAVI-C002 (MVA),
IAVI-P002 (DNA + MVA) and IAVI-V001 (DNA +
rAd5).
Methods
Abs were purified from the plasma or serum of vacci-
nees. IgGs were then assayed for ADCC, ADCP, NK
degranulation and cytokine production, antibody isotype
selection, and Ab affinity for Fc-receptors ( FcgRIIa,
FcgRIIb and FcgRIIIa).
Results
IAVI-C002 and IAVI-P002 vaccination induced negligi-
ble Fc-mediated innate immune responses, while IAVI-
V001 was able to induce ADCP in 33% of vaccines.
IPCAVD001 was also able to induce strong ADCP in
90% of subjects, but only weak ADCC, NK degranula-
tion or cytokine release. Interestingly, only RV144 and
VAX003 vaccination induced strong ADCC, ADCP, NK
degranulation and cytokine responses. Furthermore, Abs
induced by RV144 and IPCAVD exhibited a more poly-
functional profile compared to VAX003, associated with
a skewed isotype distribution of HIV-specific Abs and
selective Fc-receptor affinity binding profile.
Conclusion
These data suggest for the first time that distinct vac-
cine regimens, and vaccine vectors, may selectively
induce antibodies with Fc-enhanced functional profiles
able to elicit polyfunctional antibody responses, that
may provide improved protection from infection.
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